XGN

Exagen Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

15.94
+1.51
+10.46%
After Hours: 15.94 0 0.00% 16:00 03/31 EDT
OPEN
14.15
PREV CLOSE
14.43
HIGH
16.67
LOW
14.00
VOLUME
34.50K
TURNOVER
--
52 WEEK HIGH
29.86
52 WEEK LOW
11.54
MARKET CAP
201.28M
P/E (TTM)
-4.8715
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average XGN stock price target is 18.00 with a high estimate of 19.00 and a low estimate of 17.00.

EPS

XGN News

More
  • Exagen EPS beats by $0.10, misses on revenue
  • seekingalpha · 6d ago
  • Exagen Inc. (XGN) CEO Ron Rocca on Q4 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript · 6d ago
  • Exagen Inc. Reports Fourth Quarter and Full Year 2019 Results
  • GlobeNewswire · 6d ago
  • Exagen Inc to Host Earnings Call
  • ACCESSWIRE · 6d ago

Industry

Medical Equipment, Supplies & Distribution
-0.22%
Healthcare Equipment & Supplies
-0.66%

Hot Stocks

Symbol
Price
%Change

About XGN

Exagen Inc. is a commercial-stage life sciences company. The Company offers physicians testing for patients and healthcare providers in diagnosis, prognosis and monitoring of autoimmune conditions. Its diagnostic tests include AVISE connective tissue disease (CTD), AVISE Lupus and AVISE antiphospholipid syndrome (APS). Its prognostic tests include AVISE systemic lupus erythematosus (SLE) Prognostic, AVISE Platelet-bound C4d (PC4d) and AVISE Anti- carbamylated proteins (CarP). Its monitoring tests include AVISE SLE Monitor, AVISE methotrexate (MTX) and AVISE hydroxychloroquine (HCQ).
More

Webull offers kinds of Exagen Inc stock information, including NASDAQ:XGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XGN stock news, and many more online research tools to help you make informed decisions.